HighRes Biosolutions
Automating labs for life sciences.
Beverly, MA, United States
HighRes Biosolutions is a leader in the design and construction of innovative robotic systems and laboratory devices for pharmaceutical, biotech, and academic research laboratories. The company accelerates drug discovery, high-throughput genotyping, siRNA screening, next-generation sequencing sample prep, biorepository science, and molecular diagnostics, with a focus on the biopharmaceutical market.
How We Help
Problem Statement
Scientific research and drug development laboratories often face challenges with inefficiency, lack of reproducibility, and manual effort in their processes, hindering the speed and scalability needed for advanced life sciences research.
Core Technology
robotic systems and laboratory devices, modular workcells, MicroDock docking stations, Cellario scheduling software
Key Differentiators
Modularity, flexibility, and scalability of automation systems; Cellario™ software for seamless integration; significant increase in efficiency and reduction of errors; acceleration of drug development and research; strong customer service and support; commitment to quality; engagement in advancing AI-driven autonomous laboratories.
Target Customers
Life sciences companies, research institutions, pharmaceutical companies, academic labs, and organizations involved in molecular diagnostics and biorepository science.
Product Stage
Mature
Company Info
- Business Model
- B2B
- Founded
- 2004
- Total Funding
- 2,480,000
- Website
- highresbio.com
Categories
Disease Areas
Technologies
Clinical & IP
IP Protection
Patented MicroDock™ docking station mentioned, indicating patent holdings.
MedStartr Index Score
?What do you think of HighRes Biosolutions?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.